Berlin, Germany

Roland Kühne

This inventor holds 1 USPTO granted patent. Top assignee: Zentaris Ag. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Kühne. Retrieved from https://idiyas.com/inventor/roland-kühne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roland Kühne: Innovator in Hormonal Antagonists

Introduction

Roland Kühne is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hormonal antagonists. His work focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

Kühne holds a patent for "Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone." This invention relates to new quinoline, isoquinoline, and phthalazine derivatives that serve as antagonists of the gonadotropin-releasing hormone. This advancement could lead to new therapeutic options in hormone-related treatments.

Career Highlights

Throughout his career, Roland Kühne has demonstrated a commitment to research and innovation. His work has led to the development of a patent that showcases his expertise in medicinal chemistry. He is associated with Zentaris AG, a company that focuses on developing innovative therapies.

Collaborations

Kühne has collaborated with notable colleagues, including Peter Strehlke and Peter Droescher. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Roland Kühne is a distinguished inventor whose work in hormonal antagonists has the potential to influence medical treatments significantly. His patent and collaborations highlight his contributions to the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…